PREVALENCE AND RISK FACTORS OF FATTY LIVER DISEASE ASSESSED BY FIBROSCAN IN OUTPATIENTS: A CROSS-SECTIONAL STUDY FROM DUHOK, IRAQ
Duhok Medical Journal · 01.07.2026 · 20 (2) · 50-62
DOI: 10.31386/dmj.2026.20.2.5 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Duhok Medical Journal, online erschienen am 01.07.2026. Verfasst von RAMADHAN SALAHALDEEN ISSA.
Abstract (Originalsprache)
Background
Cirrhosis is a leading cause of morbidity and mortality among individuals with chronic liver disease. This study aimed to determine the prevalence of fatty liver, associated risk factors, and cirrhosis in patients attending a private outpatient clinic.
Methods
This prospective cross-sectional study enrolled 195 patients from an outpatient clinic in Duhok City. Eligible participants underwent liver fibrosis assessment using the FibroScan® device for evaluating hepatic fibrosis.
Results
The study sample had a mean age of 45.23 years (SD = 15.1) and included 48.7% young adults, 36.9% middle-aged individuals, and 14.4% elderly participants; 54.4% were male. Key risk factors included smoking (51.8%), diabetes (12.3%), hypertension (5.6%), and hepatitis B virus (HBV) infection (4.6%). Steatosis was absent in 5.13% of cases, while 94.87% exhibited some degree of steatosis: mild (6.15%), moderate (12.82%), or severe (75.9%). Moderate fibrosis was the most common form, followed by severe fibrosis (9%). The prevalence of cirrhosis among outpatients was 8%. Overall, the prevalence of non-alcoholic fatty liver disease (NAFLD) was 39%. Cirrhosis was significantly more prevalent in elderly patients compared to middle-aged and young individuals: 64.29% (OR: 6.75; 95% CI: 2.70–16.89) and 52.78% (OR: 4.19; 95% CI: 2.13–8.24), respectively, versus 21.05% in the young group (p < 0.0001). Diabetic patients also had a higher prevalence of cirrhosis compared to non-diabetics (58.33% vs. 36.26%; OR: 5.46; 95% CI: 1.03–5.87).
Conclusions
The prevalence of cirrhosis and NAFLD in outpatients was high and was related to older age and hypertension.
Zitieren
APA
ISSA, R. S. (2026). PREVALENCE AND RISK FACTORS OF FATTY LIVER DISEASE ASSESSED BY FIBROSCAN IN OUTPATIENTS: A CROSS-SECTIONAL STUDY FROM DUHOK, IRAQ. Duhok Medical Journal, 20(2), 50-62. https://doi.org/10.31386/dmj.2026.20.2.5
Vancouver
ISSA RS. PREVALENCE AND RISK FACTORS OF FATTY LIVER DISEASE ASSESSED BY FIBROSCAN IN OUTPATIENTS: A CROSS-SECTIONAL STUDY FROM DUHOK, IRAQ. Duhok Medical Journal. 2026;20(2):50-62. doi:10.31386/dmj.2026.20.2.5
BibTeX
@article{ISSA2026,
author = {ISSA, RAMADHAN SALAHALDEEN},
title = {PREVALENCE AND RISK FACTORS OF FATTY LIVER DISEASE ASSESSED BY FIBROSCAN IN OUTPATIENTS: A CROSS-SECTIONAL STUDY FROM DUHOK, IRAQ},
journal = {Duhok Medical Journal},
year = {2026},
volume = {20},
number = {2},
pages = {50--62},
doi = {10.31386/dmj.2026.20.2.5}
}
EUVIMED